» Authors » Patrick S Plum

Patrick S Plum

Explore the profile of Patrick S Plum including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 146
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Plum P, Niebisch S, Gockel I
Visc Med . 2024 Dec; 40(6):293-298. PMID: 39664092
Background: Achalasia is a motility disorder of the esophagus and depending on its type, esophageal tubular hypo- or hypermotility can cause typical symptoms, such as dysphagia, chest pain, weight loss,...
2.
Heinrichs L, Fluegen G, Loosen S, Loberg C, Wittig L, Quaas A, et al.
BJC Rep . 2024 Sep; 2(1):72. PMID: 39323978
Background: Biliary tract cancer (BTC) is one of the most aggressive malignancies and surgery represents the only curative treatment approach. However, even in patients with complete tumor resection 5-year survival...
3.
4.
Yang C, Cheng W, Plum P, Koppe J, Gockel I, Thieme R
J Cancer Res Clin Oncol . 2024 Aug; 150(8):399. PMID: 39180548
Purpose: This study explored the association between triglyceride-glucose (TyG), TyG index with body mass index (TyG-BMI), triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C), metabolic score for insulin resistance (IR) (METS-IR) and the...
5.
Plum P, Monig S, Gockel I, Keller G, Ott K
Chirurgie (Heidelb) . 2024 Aug; 95(9):685-695. PMID: 39120691
Benign and malignant diseases of the upper gastrointestinal tract show gender-specific differences. The frequent gastroesophageal reflux disease is a prime example: men have an erosive reflux disease more often than...
6.
Plum P, Mehdorn M, Gockel I
Chirurgie (Heidelb) . 2024 Aug; 95(9):760-761. PMID: 39090451
No abstract available.
7.
Plum P, Hess T, Bertrand D, Morgenstern I, Velazquez Camacho O, Jonas C, et al.
Clin Transl Med . 2024 Jun; 14(6):e1723. PMID: 38877653
Background: Cholangiocarcinoma (CCA) is a fatal cancer of the bile duct with a poor prognosis owing to limited therapeutic options. The incidence of intrahepatic CCA (iCCA) is increasing worldwide, and...
8.
Plum P, Barutcu A, Pamuk A, Mallmann C, Chon S, Chiapponi C, et al.
Int J Surg . 2023 May; 109(8):2324-2333. PMID: 37222663
Background: Residual tumor at the resection margins after surgery for gastric and gastroesophageal junction (GEJ) adenocarcinoma is a known prognostic factor. In this single-center, retrospective cohort study in a tertiary...
9.
Gebauer F, Plum P, Damanakis A, Chon S, Popp F, Zander T, et al.
Ann Surg Oncol . 2023 May; 30(12):7422-7433. PMID: 37210683
Background: The question of the ideal neoadjuvant therapy for locally advanced esophagogastric adenocarcinoma has not been answered to date. Multimodal treatment has become a standard treatment for these adenocarcinomas. Currently,...
10.
Plum P, Pamuk A, Barutcu A, Mallmann C, Niesen E, Berlth F, et al.
J Cancer Res Clin Oncol . 2023 Mar; 149(10):7679-7688. PMID: 37000260
Purpose: Diagnosis and treatment of gastric and gastroesophageal junction cancer have undergone many critical changes during the last two decades. We addressed the question of how clinical reality outside of...